Clinical Phase 1 Testing of the Safety and Immunogenicity of an Epitope-Based DNA Vaccine in Human Immunodeficiency Virus Type 1-Infected Subjects Receiving Highly Active Antiretroviral Therapy
Clin. Vaccine Immunol.
Wilson et al.
15: 986
Supplemental material
Files in this Data Supplement:
- Supplemental file 1
-
EP HIV-1090 DNA plasmid sequence.
Word document, 40K.
- Supplemental file 2
-
Description of the EP HIV-1090 vector backbone, including the derivation of plasmid pMB75.6 (Fig. S1) and a map of the pMB75.6 vector backbone (Fig. S2).
Word document, 63K.
